NCT06880848View on ClinicalTrials.gov

Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China

PHASE4CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

June 21, 2023

Primary Completion Date

August 26, 2025

Study Completion Date

August 26, 2025

Conditions

Carcinoma, Basal Cell (BCC)

Interventions

DRUG

Sonidegib Phosphate Capsules

Sonidegib should be taken 1 hour before or 2 hours after a breakfast

Trial Locations (1)

100034

Peking University First Hospital, Beijing

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Sun Pharmaceutical Industries Limited

INDUSTRY

collaborator

Zhejiang Hangyu Pharmaceutical Co., Ltd.

INDUSTRY

lead

Jemincare

INDUSTRY

NCT06880848 - Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China | Biotech Hunter | Biotech Hunter